{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:32:22Z","timestamp":1794493942942,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clinre.2021.101702","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:17:26Z","timestamp":1618481846000},"page":"101702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angioedema with severe acute abdominal pain: Think of hereditary angioedema"],"prefix":"10.1016","volume":"45","author":[{"given":"Nayla","family":"Mumneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Tick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Borum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2021.101702_bib0430","series-title":"National hospital ambulatory medical care survey: 2016 emergency department summary tables","author":"Centers for Disease Control","year":"2019"},{"key":"10.1016\/j.clinre.2021.101702_bib0435","first-page":"435","article-title":"Hereditary angioedema: what the gastroenterologist needs to know","volume":"7","author":"Ali","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2021.101702_bib0440","first-page":"971","article-title":"Evaluation of acute abdominal pain in adults","volume":"77","author":"Cartwright","year":"2008","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0445","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0450","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"84","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.clinre.2021.101702_bib0460","first-page":"1443","article-title":"Unnecessary abdominal interventions in patients with hereditary angioedema","volume":"16","author":"Hahn","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"issue":"11\u201312","key":"10.1016\/j.clinre.2021.101702_bib0465","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1093\/milmed\/usy031","article-title":"Extremely delayed diagnosis of type II hereditary angioedema: case report and review of the literature","volume":"13","author":"Berger","year":"2018","journal-title":"Mil Med"},{"key":"10.1016\/j.clinre.2021.101702_bib0470","unstructured":"FDA. The voice of the patient. Available at: https:\/\/www.fda.gov\/media\/113509\/download."},{"issue":"6","key":"10.1016\/j.clinre.2021.101702_bib0475","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WOX.0b013e31817aecbe","article-title":"Angioedema","volume":"1","author":"Kaplan","year":"2008","journal-title":"World Allergy Organ J"},{"issue":"8","key":"10.1016\/j.clinre.2021.101702_bib0480","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema \u2013 the 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0485","doi-asserted-by":"crossref","first-page":"212","DOI":"10.18176\/jiaci.0087","article-title":"Novelties in the diagnosis and treatment of angioedema","volume":"26","author":"Cicardi","year":"2016","journal-title":"J Invest Allergol Clin Immunol"},{"issue":"39","key":"10.1016\/j.clinre.2021.101702_bib0490","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.3748\/wjg.v16.i39.4913","article-title":"Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective","volume":"16","author":"Nzeako","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2021.101702_bib0495","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1111\/bjh.14059","article-title":"How we manage persons with hereditary angioedema","volume":"173","author":"Zuraw","year":"2016","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.clinre.2021.101702_bib0500","doi-asserted-by":"crossref","first-page":"391","DOI":"10.12968\/hmed.2019.80.7.391","article-title":"Hereditary angioedema: an update on causes, manifestations and treatment","volume":"80","author":"Longhurst","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0505","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","article-title":"A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor","volume":"141","author":"Bork","year":"2011","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0510","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.clinre.2021.101702_bib0515","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2017.12.060","article-title":"A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor","volume":"498","author":"Dewald","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.clinre.2021.101702_bib0525","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/all.13869","article-title":"Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin","volume":"74","author":"Bork","year":"2019","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.clinre.2021.101702_bib0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0535","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0540","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anai.2013.08.019","article-title":"The burden of illness in patients with hereditary angioedema","volume":"111","author":"Banerji","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.clinre.2021.101702_bib0545","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S1081-1206(10)60584-4","article-title":"Hereditary angiodema: a current state-of-the-art review: VII. Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema","volume":"100","author":"Bowen","year":"2008","journal-title":"Ann Allergy Asthma lmmunol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0550","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2500\/aap.2009.30.3279","article-title":"Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks","volume":"30","author":"Prematta","year":"2009","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0555","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2500\/aap.2009.30.3278","article-title":"Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review","volume":"30","author":"Kemp","year":"2009","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0560","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2005.02726.x","article-title":"C1 inhibitor deficiency: consensus document","volume":"139","author":"Gompels","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0565","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0570","first-page":"391","article-title":"Intestinal angioedema misdiagnosed as recurrent episodes of gastroenteritis","volume":"11","author":"Locasio","year":"2010","journal-title":"West J Emerg Med"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0575","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein","year":"2017","journal-title":"Int J Emerg Med"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0580","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaip.2019.05.056","article-title":"Development of the hereditary angioedema rapid triage tool","volume":"8","author":"Betschel","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0585","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000486312","article-title":"Hereditary and acquired angioedema: heterogeneity of pathogenesis and clinical phenotypes","volume":"175","author":"Bova","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0590","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"American College of Allergy, Asthma & Immunology (ACAAI); Society for Academic Emergency Medicine (SAEM). A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.clinre.2021.101702_bib0595","unstructured":"Lo Loestrin\u00ae Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) prescribing information. Available at: https:\/\/media.allergan.com\/actavis\/actavis\/media\/allergan-pdf-documents\/product-prescribing\/NDA-22501-Lo-Loestrin-Fe-PI-CLEAN-08-2017_ver1.pdf."},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0600","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2004.09.032","article-title":"Angioedema","volume":"53","author":"Kaplan","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0605","article-title":"Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study","volume":"5","author":"Schulkes","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.clinre.2021.101702_bib0610","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-230X-14-71","article-title":"Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency","volume":"14","author":"Rubinstein","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0615","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.anai.2016.08.014","article-title":"IOS Study Group Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting","volume":"117","author":"Zanichelli","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0620","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","article-title":"Hereditary angio-oedema in Denmark: a nationwide survey","volume":"161","author":"Bygum","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0625","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.cgh.2017.07.026","article-title":"Hereditary angioedema: an overlooked cause of recurrent abdominal pain and free peritoneal fluid","volume":"16","author":"Eder","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"10.1016\/j.clinre.2021.101702_bib0630","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","article-title":"Hereditary angioedema: a broad review for clinicians","volume":"161","author":"Nzeako","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0635","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MEG.0b013e328343d3b2","article-title":"Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?","volume":"23","author":"Csuka","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101702_bib0640","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmed.2019.00080","article-title":"Hereditary angioedema-associated acute pancreatitis in C1-inhibitor deficient and normal C1-inhibitor patients: case reports and literature review","volume":"6","author":"Veronez","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0645","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/14656566.2017.1282461","article-title":"Current and future therapies for the treatment of histamine-induced angioedema","volume":"18","author":"James","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.clinre.2021.101702_bib0650","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2010.01.024","article-title":"Economic costs associated with acute attacks and long-term management of hereditary angioedema","volume":"104","author":"Wilson","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"20","key":"10.1016\/j.clinre.2021.101702_bib0655","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2018.16773","article-title":"Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized control trial","volume":"320","author":"Banerji","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2021.101702_bib0660","unstructured":"KALBITOR\u00ae [package insert]. Burlington, MA: Dyax Corp.; 2015."},{"key":"10.1016\/j.clinre.2021.101702_bib0665","unstructured":"FIRAZYR\u00ae [package insert]. Lexington, MA, USA: Shire Orphan Therapies LLC; 2015."},{"key":"10.1016\/j.clinre.2021.101702_bib0670","unstructured":"BERINERT\u00ae [package insert]. Marburg, Germany: CSL Behring GmbH; 2019."},{"key":"10.1016\/j.clinre.2021.101702_bib0675","unstructured":"RUCONEST\u00ae (C1 esterase inhibitor [recombinant]). Prescribing Information. Pharming Healthcare Inc. Bridgewater, NJ; 2018."},{"key":"10.1016\/j.clinre.2021.101702_bib0680","unstructured":"DANOCRINE\u00ae [package insert]. Bridgewater, NJ, USA; Sanofi-aventis US LLC; 2011."},{"key":"10.1016\/j.clinre.2021.101702_bib0685","unstructured":"CINRYZE\u00ae [package insert]. Exton, PA, USA: ViroPharma Biologics, Inc.; 2018."},{"key":"10.1016\/j.clinre.2021.101702_bib0690","unstructured":"HAEGARDA\u00ae (C1 esterase inhibitor subcutaneous [human]). Prescribing Information. CSL Behring, Marburg, Germany; 2017"},{"key":"10.1016\/j.clinre.2021.101702_bib0695","unstructured":"TAKHZYRO\u2122 (lanadelumab-flyo). Prescribing information. Dyax Corp. Lexington, MA, USA; 2018."},{"key":"10.1016\/j.clinre.2021.101702_bib0700","unstructured":"ORLADEYO\u2122 [package insert]. Durham, NC, USA: BioCryst Pharmaceuticals, Inc.; 2020."},{"key":"10.1016\/j.clinre.2021.101702_bib0705","unstructured":"LYSTEDA\u2122 (tranexamic acid). Tablets Prescribing Information. Ferring Pharmaceuticals Inc., Parsippany, NJ; 2013."},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0710","first-page":"32","article-title":"Uses of tranexamic acid","volume":"15","author":"Reed","year":"2015","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.clinre.2021.101702_bib0715","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.intimp.2020.106216","article-title":"Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency","volume":"80","author":"Andrasi","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinre.2021.101702_bib0720","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaip.2019.08.011","article-title":"Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema","volume":"8","author":"Valerieva","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0725","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","article-title":"US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency","volume":"1","author":"Zuraw","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clinre.2021.101702_bib0730","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advistory Board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0735","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2500\/aap.2008.29.3107","article-title":"Appraisal of danazol prophylaxis for hereditary angioedema","volume":"29","author":"Craig","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clinre.2021.101702_bib0740","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/IJWH.S46460","article-title":"Management of hereditary angioedema in pregnant women: a review","volume":"6","author":"Caballero","year":"2014","journal-title":"Int J Womens Health"},{"issue":"9","key":"10.1016\/j.clinre.2021.101702_bib0745","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00431-012-1726-4","article-title":"Hereditary angioedema (HAE) in children and adolescents \u2013 a consensus on therapeutic strategies","volume":"171","author":"Wahn","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.clinre.2021.101702_bib0750","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WOX.0b013e318279affa","article-title":"WAO Guideline for the management of hereditary angioedema","volume":"5","author":"Craig","year":"2012","journal-title":"World Allergy Organ J"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0755","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaip.2013.04.003","article-title":"Implantable venous access device associated complications in patients with hereditary angioedema","volume":"1","author":"Yoo","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.clinre.2021.101702_bib0760","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1503\/cmaj.121364","article-title":"Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema","volume":"185","author":"Rizk","year":"2013","journal-title":"CMAJ"},{"issue":"12","key":"10.1016\/j.clinre.2021.101702_bib0765","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0770","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-018-0797-3","article-title":"Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert\u00ae) in patients with hereditary angioedema: the SABHA study","volume":"13","author":"Zanichelli","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.clinre.2021.101702_bib0775","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/cea.13220","article-title":"Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema","volume":"48","author":"Pawaskar","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.clinre.2021.101702_bib0780","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cei.12820","article-title":"Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema","volume":"185","author":"Deroux","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.clinre.2021.101702_bib0785","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/all.13076","article-title":"Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)","volume":"72","author":"Bork","year":"2017","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.clinre.2021.101702_bib0790","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","article-title":"Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor","volume":"376","author":"Longhurst","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0795","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jaip.2017.12.039","article-title":"Health-related quality of life with subcutaneous C1-inhibitor for prevention of attacks of hereditary angioedema","volume":"6","author":"Lumry","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.clinre.2021.101702_bib0800","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/all.12658","article-title":"Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate","volume":"70","author":"Zuraw","year":"2015","journal-title":"Allergy"},{"issue":"25","key":"10.1016\/j.clinre.2021.101702_bib0805","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101702_bib0810","article-title":"Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial","author":"Zuraw","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.clinre.2021.101702_bib0815","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0820","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2500\/aap.2013.34.3620","article-title":"Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency","volume":"34","author":"Patel","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0825","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/ejd.2013.2252","article-title":"Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema","volume":"24","author":"Manson","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0830","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-019-1043-3","article-title":"Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate","volume":"14","author":"Bork","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2021.101702_bib0835","article-title":"ACE inhibitor-induced angioedema","author":"Guyer","year":"2019","journal-title":"UpToDate"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0840","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"NEJM"},{"issue":"5","key":"10.1016\/j.clinre.2021.101702_bib0845","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"CAMEO study group Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.clinre.2021.101702_bib0850","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:28Z","timestamp":1761895828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2210740121000814"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101702","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angioedema with severe acute abdominal pain: Think of hereditary angioedema","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101702"}}